Literature DB >> 23120762

Performance of the definitions of the systemic inflammatory response syndrome and sepsis in neonates.

Nora Hofer1, Eva Zacharias, Wilhelm Müller, Bernhard Resch.   

Abstract

AIMS: The aim of this study was to examine the applicability of the definitions of the systemic inflammatory response syndrome (SIRS) and sepsis to neonates during the first 3 days of life.
METHODS: This is a retrospective study of all term neonates hospitalized within the first 24 h of life from 2004 to 2010 at our neonatal intensive care unit.
RESULTS: Of 476 neonates, 30 (6 %) had a diagnosis of culture-proven early-onset sepsis (EOS) and 81 (17 %) had culture-negative clinical EOS or suspected EOS. SIRS and sepsis criteria were applied to 116 (24 %) and 61 (13 %) neonates, respectively. Of 30 neonates with culture proven, EOS 14 (53 %) fulfilled SIRS and sepsis criteria. The single diagnostic criterion of SIRS applied to 20 % (hypothermia or fever), 43 % (white blood cell count/immature-to-total neutrophil ratio), 87 % (respiratory symptoms), and 33 % (cardiocirculatory symptoms) of all neonates with culture-proven EOS.
CONCLUSIONS: The definitions of SIRS and sepsis did not apply to about half of all cases of culture-proven EOS. An evidence-based approach to find the appropriate criteria for defining EOS in the neonate is needed.

Entities:  

Mesh:

Year:  2012        PMID: 23120762     DOI: 10.1515/jpm-2011-0308

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  12 in total

Review 1.  Time for a neonatal-specific consensus definition for sepsis.

Authors:  James L Wynn; Hector R Wong; Thomas P Shanley; Matthew J Bizzarro; Lisa Saiman; Richard A Polin
Journal:  Pediatr Crit Care Med       Date:  2014-07       Impact factor: 3.624

2.  [Unifying criteria for late neonatal sepsis: proposal for an algorithm of diagnostic surveillance].

Authors:  Alonso Zea-Vera; Christie G Turin; Theresa J Ochoa
Journal:  Rev Peru Med Exp Salud Publica       Date:  2014-04

Review 3.  Vital signs as physiomarkers of neonatal sepsis.

Authors:  Brynne A Sullivan; Karen D Fairchild
Journal:  Pediatr Res       Date:  2021-09-07       Impact factor: 3.756

Review 4.  Defining neonatal sepsis.

Authors:  James L Wynn
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

5.  Validation of the Sepsis MetaScore for Diagnosis of Neonatal Sepsis.

Authors:  Timothy E Sweeney; James L Wynn; María Cernada; Eva Serna; Hector R Wong; Henry V Baker; Máximo Vento; Purvesh Khatri
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

6.  Evaluation of compliance with the 2017 Canadian Paediatric Society Position Statement for the management of newborns at risk for early-onset sepsis: A retrospective cohort study.

Authors:  Marina Simeonova; Jolanta Piszczek; Sannifer Hoi; Curtis Harder; Gustavo Pelligra
Journal:  Paediatr Child Health       Date:  2020-04-08       Impact factor: 2.253

7.  Comparison Between Pathogen Associated Laboratory and Clinical Parameters in Early-Onset Sepsis of the Newborn.

Authors:  Bernhard Resch; Renoldner B; Hofer N
Journal:  Open Microbiol J       Date:  2016-06-30

8.  Performance Comparison of Systemic Inflammatory Response Syndrome with Logistic Regression Models to Predict Sepsis in Neonates.

Authors:  Jyoti Thakur; Sharvan Kumar Pahuja; Roop Pahuja
Journal:  Children (Basel)       Date:  2017-12-19

9.  Timing of Multiorgan Dysfunction among Hospitalized Infants with Fatal Fulminant Sepsis.

Authors:  James L Wynn; Matthew S Kelly; Daniel K Benjamin; Reese H Clark; Rachel Greenberg; Daniel K Benjamin; P Brian Smith
Journal:  Am J Perinatol       Date:  2016-12-06       Impact factor: 3.079

10.  Comparison of early onset sepsis and community-acquired late onset sepsis in infants less than 3 months of age.

Authors:  Shlomi Bulkowstein; Shalom Ben-Shimol; Noga Givon-Lavi; Rimma Melamed; Eilon Shany; David Greenberg
Journal:  BMC Pediatr       Date:  2016-07-07       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.